MOTS-c 40mg Dosage: What a 40mg Vial Really Means

A 40mg MOTS-c vial is a quantity of peptide, not a single dose, which is why most MOTS-c 40mg dosage questions do not have one clean answer. The amount you actually inject depends on how much bacteriostatic water you add and how many units you draw into the syringe. Most published research protocols use roughly 5 to 10 mg per week split across two or three subcutaneous injections, so a single 40mg vial typically lasts four to eight weeks at those research levels.

What the "40mg" on a MOTS-c Vial Actually Means

MOTS-c is a mitochondrial-derived peptide studied for its role in metabolic regulation, insulin sensitivity, and exercise response. It is not FDA-approved for human use in the United States and is sold only as a research chemical. A 40mg vial holds 40 milligrams of lyophilized, or freeze-dried, peptide powder.

That number describes the total contents of the vial, not the size of any individual injection.

• 40mg = total peptide in the vial, measured before any liquid is added.
• Reconstitution volume decides how concentrated each injection becomes.
• Syringe units decide how much peptide you actually draw and inject.

Because the vial size is fixed and the dose is a choice, two researchers can own identical 40mg vials and run very different protocols from them.

How to Reconstitute a 40mg MOTS-c Vial

Reconstitution is the step that turns powder into an injectable solution. The volume of bacteriostatic water you add sets the concentration, and every dose afterward is calculated from that number.

1. Let the vial reach room temperature and swab the rubber stopper with an alcohol pad.
2. Draw your chosen volume of bacteriostatic water into a new syringe.
3. Aim the stream at the glass wall rather than directly at the powder to reduce foaming.
4. Swirl gently until the powder dissolves completely. Do not shake the vial.
5. Refrigerate the reconstituted vial and keep it away from light.

With 2 mL of water, a 40mg vial becomes 20 mg/mL. On a standard U-100 insulin syringe, one unit equals 0.01 mL, so each unit delivers about 0.2 mg of MOTS-c.

Bacteriostatic water added	Concentration	Units for 2.5 mg	Units for 5 mg	Units for 10 mg
1 mL	40 mg/mL	6.25 units	12.5 units	25 units
2 mL	20 mg/mL	12.5 units	25 units	50 units
4 mL	10 mg/mL	25 units	50 units	100 units

Typical MOTS-c Peptide Dosage Protocol in Research

No FDA-approved human dose of MOTS-c exists, and no large randomized trial has established one. What exists is a mix of animal studies, small human observational work, and community-reported protocols. A widely referenced mots-c peptide dosage protocol uses one of three weekly totals:

• 5 mg per week, split into two 2.5 mg injections.
• 10 mg per week, split into two 5 mg injections or three injections of about 3.3 mg.
• 20 mg per week, split into two 10 mg injections, which is less common and mostly anecdotal.

A typical mots-c dosage chart places 10 mg per week in the middle of the reported range, with 5 mg at the low end and 20 mg at the high end. Injections are usually subcutaneous, often in the morning or before training.

Protocol level	Weekly total	Injections per week	Per-injection amount
Low	5 mg	2	2.5 mg
Moderate	10 mg	2 or 3	5 mg or 3.3 mg
High	20 mg	2	10 mg

Why the 40mg Vial Size Is Popular

Buying a mots-c 40mg vial often costs less per milligram than buying four separate 10mg vials. It also means fewer shipments, fewer reconstitutions, and a longer window before reordering.

At 10 mg per week, a 40mg vial lasts about four weeks. At 5 mg per week, it stretches to roughly eight weeks. The trade-off is that one large vial commits you to a single batch, so proper refrigeration and handling matter more.

People searching for mots c dosage for weight loss often find the same 5 to 10 mg weekly range cited in metabolic research. No completed human trial has shown that MOTS-c produces weight loss in people, so those numbers describe research practice, not a proven fat-loss dose.

40mg vs 10mg vs 5mg Vials at a Glance

Vial size	Weeks at 5 mg/week	Weeks at 10 mg/week	Best suited for
5 mg	1 week	0.5 week	Trial runs and single-week protocols
10 mg	2 weeks	1 week	Short protocols or dose adjustments
40 mg	8 weeks	4 weeks	Longer multi-week research cycles

Smaller vials offer flexibility, while larger vials lower the cost per milligram. Researchers who are still dialing in their dosing usually start small, and researchers who have settled on a routine usually move up.

Stacking MOTS-c With Other Research Peptides

MOTS-c is sometimes studied alongside other metabolic compounds, including GLP-1 receptor agonists, tesamorelin, and AOD-9604. Protocols that explore a reta and mots-c stack dosage typically separate the two compounds into different injection times to avoid overlapping absorption.

Stacking increases the number of variables in any protocol and makes side effects harder to attribute to a single compound. Anyone considering a stack should review each peptide's individual profile first.

Safety, Side Effects, and Legal Status

MOTS-c is not FDA-approved for human use, and vials sold online are labeled "for research purposes only." Purity, sterility, and actual peptide content are not verified by any regulator.

Anecdotal reports mention injection-site irritation, fatigue, and mild gastrointestinal discomfort. Serious human safety data are limited, so anyone considering MOTS-c should speak with a licensed healthcare professional first.

Key Takeaways

• A 40mg MOTS-c vial is a total quantity of peptide, not a single dose.
• Reconstitution volume determines how many milligrams each syringe unit delivers.
• Most research protocols use 5 to 10 mg per week split into two or three subcutaneous injections.
• A 40mg vial lasts roughly four weeks at 10 mg per week and eight weeks at 5 mg per week.
• MOTS-c is not approved by the FDA for human use in the United States.

COMMON QUESTIONS

Frequently Asked Questions

How much MOTS-c do you inject from a 40mg vial?

It depends on how much bacteriostatic water you add. If you reconstitute a 40mg vial with 2 mL of water, the concentration is 20 mg/mL, and a 5 mg dose equals 25 units on a U-100 insulin syringe. Most research protocols use 2.5 to 5 mg per injection, two or three times per week.

Is 40mg of MOTS-c a single dose?

No. The 40mg figure describes the total peptide content of the vial before reconstitution, not one injection. A single research injection typically falls between 2.5 mg and 10 mg, so a 40mg vial covers many doses and usually lasts four to eight weeks.

Is MOTS-c FDA-approved or legal for human use?

MOTS-c is not FDA-approved for human use in the United States and is sold strictly as a research chemical. That means it has not been evaluated by regulators for safety, purity, or effectiveness in people, and human use carries unknown risks that are worth discussing with a healthcare professional.